---更多详情 The Washington Post /Reuters
Congress urged to clear path for generic drugs
By Susan Heavey
Thursday, July 20, 2006; 7:14 PM
WASHINGTON (Reuters) - Congress should act to protect generic drugmakers from brand-name company tactics that thwart competition and keep cheaper medicines from U.S. consumers, a generic manufacturer said on Thursday.